Authors
Scarffe, J HowardKenny, John B
Johnson, Richard J
Owens, Susan E
Giles, G
Leveson, S
Maley, Wendy V
Affiliation
Department of Medical Oncology, Cancer Research Campaign, CHristie Hospital and Holt Radium Institute, Manchester, EnglandIssue Date
1985-11
Metadata
Show full item recordAbstract
Patients with advanced inoperable or recurrent adenocarcinoma of the stomach received an iv bolus of epirubicin (75 mg/m2) every 3 weeks. Partial responses were observed in four of 24 evaluable patients (17%). Treatment was generally well tolerated; a drop in left ventricular ejection fraction was observed in one patient who had received 450 mg/m2 of epirubicin.Citation
Phase II trial of epirubicin in gastric cancer. 1985, 69 (11):1275-7 Cancer Treat RepJournal
Cancer Treatment ReportsPubMed ID
3867402Type
ArticleLanguage
enISSN
0361-5960Collections
Related articles
- [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
- Authors: Kimura K, Suga S, Kano H, Sakakibara K, Hayashi T, Nakai T, Nagano I, Yokoyama Y, Morise K, Hayakawa M
- Issue date: 1986 Jul
- [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
- Authors: Sakata Y, Yoshida Y
- Issue date: 1986 May
- A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
- Authors: Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E
- Issue date: 1996 Oct
- A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
- Authors: Woo IS, Moon DH, Shim BY, Lee MA, Byun JH, Kim KW, Kang JH, Choi MG, Chung IS, Hong YS, Park SY, Lee KS
- Issue date: 2005 Jan
- Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
- Authors: Karlin DA, Stroehlein JR, Bennetts RW, Jones RD, Heifetz LJ, Mahal PS
- Issue date: 1982 Aug